Your browser doesn't support javascript.
loading
In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.
Cho, Hye-Kyung; Karau, Melissa J; Greenwood-Quaintance, Kerryl E; Hansford, Karl A; Cooper, Matthew A; Blaskovich, Mark A T; Patel, Robin.
Afiliação
  • Cho HK; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN.
  • Karau MJ; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN.
  • Greenwood-Quaintance KE; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN.
  • Hansford KA; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, 4072, Australia.
  • Cooper MA; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, 4072, Australia.
  • Blaskovich MAT; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, 4072, Australia patel.robin@mayo.edu m.blaskovich@uq.edu.au.
  • Patel R; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN patel.robin@mayo.edu m.blaskovich@uq.edu.au.
Article em En | MEDLINE | ID: mdl-33685894
ABSTRACT
MRSA periprosthetic 1 joint infection (PJI) can be challenging to treat due to biofilm formation, alongside sometimes limited vancomycin activity (1-3).….

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article